Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details)

v3.21.2
Stockholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Oct. 07, 2020
Jan. 31, 2021
Jan. 05, 2018
Sep. 01, 2017
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2019
Dec. 31, 2014
Jan. 31, 2011
Stockholders’ Equity (Details) [Line Items]                  
Common stock, par value (in Dollars per share)         $ 0.01 $ 0.01      
Percentage of commission payable on equity offering         3.00%        
Maximum offering price under sales agreement         $ 20,000     $ 20,000  
Shares of common stock settlements (in Shares)         208,537 333,265 315,472    
Contribution obligation         $ 780 $ 839 $ 832    
Shares of common stock in payment of accrued bonuses (in Shares)   332,700     332,700        
Accrued bonuses   $ 875     $ 875        
Shares of common stock as employee compensation (in Shares)           4,167      
Common stock as employee compensation           $ 10      
Common stock settlements         $ 832        
Common stock available for grant, description The amendment and restatement of the Amended and Restated 2011 Plan was for purposes of, among other things, (i) increasing the shares of common stock available for grant under the Amended and Restated 2011 Plan by an additional 4,000,000 shares of common stock bringing the total number of shares available for grant to 9,000,000 shares of common stock and (ii) extending the term of the Amended and Restated 2011 Plan until October 7, 2030.                
Common stock granted (in Shares)         5,066,000        
Outstanding options vested and exercisable         $ 488 0 159    
Intrinsic value of options outstanding         1,323 79 955    
Intrinsic value of options exercised         $ 38 0 $ 117    
Stock options in non-cash transactions (in Shares)             203,511    
Received net shares of common stock (in Shares)         23,376        
Performance share, description         During the fiscal year 2020, a former executive forfeited 4,000 and 10,500 PSUs from the fiscal 2019 and fiscal 2020 awards, respectively. During fiscal year 2021, a former executive forfeited 2,000 and 4,000 PSUs from the fiscal 2018 and fiscal 2019 awards, respectively. During fiscal year 2021, 26,000 remaining PSU’s awarded in fiscal 2018 to current executives with a grant date of July 31, 2018 expired as the growth goals were not achieved by July 31, 2021.        
Accrued compensation expense         $ 272        
Total restricted stock (in Shares)         817        
Fair value awards vested         $ 2 $ 2 $ 4    
Minimum [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Vest over period         2 years        
Maximum [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Vest over period         4 years        
2011 Plan [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Share based compensation arrangement by share based payment award restricted stock units (in Shares)                 3,000,000
Share-based compensation arrangement by share-based payment award, number of additional shares authorized (in Shares)     2,000,000            
Common stock available for grants (in Shares)     5,000,000            
Common Stock [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Authorized common stock that may be issued and sold under sales agreement       $ 19,200          
Securities that may be sold under the agreement       $ 150,000          
Shares of common stock in payment of accrued bonuses (in Shares)         208,537 333,265 315,472